Additional Information
Level of Instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical laboratory technicians, pathology residents, MLS students, and other health care personnel who have an interest in this subject matter.
Author information: Nancy Liu-Sullivan holds a Ph.D. in Molecular and Cellular Pharmacology from Stony Brook University School of Medicine. Dr. Liu-Sullivan served as a senior research scientist at Memorial Sloan Kettering Cancer Center (MSKCC) prior to joining the biology faculty at the College of Staten Island, City University of New York (CUNY).
Reviewer information: Ralph Garippa, Ph.D., is the Director of Gene Editing and RNAi Core Facility at Memorial Sloan Kettering Cancer Center, with more than two decades of drug discovery expertise and leadership. He is the former Head of Cell-Based High Throughput Screening and Microscopic Imaging-based High Content Screening at Hoffmann-La Roche’s Nutley, NJ facility. His previous academic partners included Harvard University, Massachusetts General Hospital, and The Hebrew University in Jerusalem, Israel. Dr. Garippa holds a Ph.D. in Pharmacology from Columbia University and a B.A. degree in Biology from Fairleigh Dickinson University.
Reviewer information: Kevin F. Foley, Ph.D., DABCC, MT, is the director of clinical pathology for the Kaiser Permanente Northwest region. He also teaches clinical chemistry at Oregon Health Sciences University. Dr. Foley earned his Ph.D. in clinical pharmacology and toxicology at East Carolina School of Medicine in North Carolina. He received a Ph.D. in clinical pharmacology and toxicology from Brody School of Medicine, Greenville, NC. He has been working in laboratory medicine for over 15 years, starting his career as a medical technologist.